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Herna´ndez, Arturo, and Maria Jesu´s Obrego´n. Triio-
dothyronine amplifies the adrenergic stimulation of uncou-
pling protein expression in rat brown adipocytes. Am J
Physiol Endocrinol Metab 278: E769–E777, 2000.—Uncou-
pling protein (UCP), the mitochondrial protein specific to
brown adipose tissue, is activated transcriptionally in re-
sponse to cold and adrenergic agents. We studied the role of
triiodothyronine (T3) on the adrenergic stimulation of UCP
mRNA expression by use of primary cultures of rat brown
adipocytes. Basal UCP mRNAlevels are undetectable. Norepi-
nephrine (NE) increases UCP mRNA during differentiation,
not during proliferation. In hypothyroid conditions, UCP
mRNA response to NE is almost absent. The presence of T3
(0.2–20 nM) greatly increases the adrenergic response (30-
fold). The sensitivity of UCP mRNA responses to NE is
potentiated ,100-fold by the presence of T3. The effect is
proportional to the dose and time of preexposure to T3. The
increases obtained with NE and T3 are prevented by actinomy-
cin and cycloheximide. T3 greatly stabilizes UCP mRNA
transcripts. The effects of thyroxine and retinoic acid are
weaker than those of T3. In conclusion, in cultured rat brown
adipocytes, T3 is required and both synergizes with NE to
increase UCP mRNA and stabilizes its mRNA transcripts.
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BROWN ADIPOSE TISSUE (BAT) is a thermogenic tissue
that plays an important role in hibernating animals,
newborns, and cold-exposed mammals. BAT also seems
important in maintaining energy balance, as it is
activated in response to diet (diet-induced thermogen-
esis). The main function of BAT is to produce heat
under adrenergic stimulation (facultative thermogen-
esis). This function is accomplished by the uncoupling
protein (UCP), nowadays called UCP-1 (UCP in this
paper), a BAT-specific protein present only in the inner
mitochondrial membrane of BAT (37). When activated
adrenergically, UCP provides heat by uncoupling the
oxidative phosphorylation, dissipating as heat the en-
ergy otherwise stored as ATP (25).
BAT thermogenesis is activated in response to the
norepinephrine (NE) released by sympathetic nerve
endings. The adrenergic stimulation induces UCP syn-
thesis, a process that has been studied in vivo in several
species and different situations, measuring increases in
the activity, protein, or UCP mRNA expression (4, 6, 16,
24, 27, 38, 46, 47). The presence of UCP has also been
characterized in isolated floating rat brown adipocytes
(2) or in primary cultures of brown adipocytes obtained
from mice or hamsters as donor animals (9, 17, 36). In
the latter culture systems, UCP mRNA is stimulated in
response to NE, adrenergic analogs, or cAMP, and the
stimulation has been characterized as b-adrenergic,
acting through the b1- and b3-adrenergic receptors (9,
17, 30, 36). Other studies have been done using murine
cell lines from hibernomas in which different sensitiv-
ity to NE was observed (18, 21, 39, 40).
Thyroid hormones are also important in thermogen-
esis. Hypothyroid animals are intolerant to cold and
even die when exposed to cold for several hours (4). This
is due to a defective basal and facultative thermogen-
esis in the hypothyroid animals, because during cold
exposure the increases in UCP expression are lower
than in control animals. This deficiency can be restored
by adequate replacement therapy with thyroxine (T4)
(4, 46). Basal and stimulated UCP mRNA is also low in
hypothyroid fetuses and newborns, and either triiodo-
thyronine (T3) or T4 restores UCP levels in fetuses (26,
28). Therefore, thyroid hormones seem necessary for
the full expression of UCP in vivo (4, 46), and T3
amplifies the adrenergic stimulation of UCP mRNA
expression and transcription in cold-exposed rats (3).
In addition, there is a high correlation between the
occupancy of nuclear T3 receptors and UCP increases
(5). Recently, certain regions of the rat UCP promoter
have been identified as thyroid hormone and retinoic
acid response elements (TRE and RARE, respectively)
(1, 8, 33, 34).
The production of T3 in BAT is catalyzed by the type
II 58-iodothyronine deiodinase (DII), an enzyme stimu-
lated mainly by cold and adrenergic agents (44); its role
is to produce T3 locally. DII seems necessary for an
optimal thermogenic response of BAT to cold (4).
Although the role of thyroid hormones for the full
expression of UCP has been well documented in rats in
vivo (3), studies using cultured rat brown adipocytes
are scarce (9), and the role and need of thyroid hor-
mones for the adrenergic stimulation of UCP are not
always recognized (9, 36) because the results depend on
the culture model used. Several groups include T3 as a
so-called ‘‘differentiation medium,’’ a beneficial factor
for the differentiation of cultured brown preadipocytes
(1, 18). Nevertheless, the precise role of T3 has not been
fully clarified in cultures of brown adipocytes.
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The aim of the present study is to study the effect of
thyroid hormones on the adrenergic stimulation of UCP
mRNA expression by use of primary cultures of rat
brown adipocytes, a system in which the stimulation of
UCP by NE is not easily achieved. Precursor cells were
isolated from rat BAT pads and, after a period of active
proliferation, were used during the differentiation pe-
riod. We analyze the role of T3 that is required and that
potentiates the adrenergic activation of UCP mRNA in
cultured rat brown preadipocytes. The present model
remarks on the importance of T3, which seems more
important than T3 as previously reported in other
culture systems.
MATERIALS AND METHODS
Materials. DMEM was obtained from Life Technologies
(Uxbridge, UK). Newborn calf serum (NCS) was purchased
from Flow (Paisley, Scotland). Antibiotics were obtained from
the local pharmacy. BSA (in solution at 22%, pH 5 7.2) was
obtained from Ortho Diagnostic Systems, Johnson & Johnson
(Raritan, NJ). Collagenase, bovine insulin, ascorbic acid,
guanidinium HCl, MOPS, T3, T4, NE, and retinoic acid (RA)
were obtained from Sigma (St. Louis, MO). Cycloheximide
(CHX), actinomycin D (Act D), and restriction enzymes were
obtained from Boehringer Mannheim (Mannheim, Germany).
Ion exchange resin AG1-X8 was from Bio-Rad (Richmond,
CA). All other chemicals were reagent or molecular biology
grade. Radiolabeled deoxy-[a-32P]CTP (3,000 Ci/mmol) was
purchased from Amersham International (Aylesbury, UK),
and the oligolabeling system was obtained from Pharmacia
(Uppsala, Sweden). Nytran membranes were purchased from
Schleicher & Schuell (Dassel, Germany).
Cultures of brown adipocytes. Precursor cells were ob-
tained from the interscapular brown adipose tissue of 20-day-
old rats (Sprague-Dawley), isolated according to the method
described by Ne´chad et al. (23), with modifications (13) by use
of collagenase digestion (0.2%) in DMEM11.5% BSA at 37°C
and filtration through 250-µm pore size silk filters. Mature
cells were allowed to float, and the infranatant was filtrated
through 25-µm pore size silk filters and centrifuged. Precur-
sor cells were seeded in 25-cm2 culture flasks to get 1,500–
2,000 cells/cm2 on day 1 and were grown in DMEM supple-
mented with 10% NCS, 3 nM insulin, 10 mM HEPES, 50 IU
penicillin, 50 µg streptomycin/ml, and 15 µM ascorbic acid.
Culture medium was changed on day 1 and every 2nd day
thereafter. Precursor cells proliferated actively under these
conditions, reached confluence on the 4th or 5th day after
seeding (40,000–80,000 cells/cm2), and by day 8 were fully
differentiated into mature brown adipocytes. Studies were
performed during the period of differentiation (5th-8th cul-
ture day) using NCS or hypothyroid serum in the presence of
thyroid hormones or other treatments, as specified.
Both NCS and hypothyroid serum (HS) were used for
culture. The latter was obtained by depleting NCS of thyroid
hormones with the anion exchange resin AG1X8, as previ-
ously described (43). HS contained #10% of the original
amount of thyroid hormones, as assessed by RIA (22). In NCS,
concentrations were 77 mM T4 and 0.7 nM T3, respectively.
These levels were decreased to 2.2 nM T4 and 0.13 nM T3 in
HS (13). These concentrations are before 10% dilution in the
culture medium.
The free T4 and T3 concentrations were measured by
ultrafiltration and RIA in the culture medium (DMEM110%
NCS): 35 pM T4 and 2.5 pM T3 (0.45 and 4% of the total T4 and
T3 concentrations, respectively). We also measured the free T3
concentrations when using DMEM1 10% HS1T3. The free T3
concentrations (at the start of the experiment) were 4% of the
total T3 added, and after 20 h, incubation decreased in
variable amounts, depending on the T3 concentration used: 50
and 170 pM T3 when 1 and 10 nM T3110% HS, respectively,
were used. In these conditions the cellular T3 concentrations
were 2.3 and 9 nM T3 for 1 and 10 nM T3, respectively
(unpublished observations).
The incorporation of 35S-labeled methionine into TCA-
precipitable proteins was determined after cells were incu-
bated for 16 h with 35S-methionine, in the presence of several
CHX doses.
RNA preparation and Northern blot analysis. Total cellular
RNA was extracted in guanidinium-HCl as described (13),
with use of ethanol precipitation. The recovery was 50–90 µg
total RNA/25-cm2 flasks, ,5 3 106 cells (,25 µg RNA in the
4th–5th days). For Northern analysis, total RNA (15–20 µg)
was denatured and electrophoresed on a 2.2 M formalde-
hyde/1% agarose gel in 13 MOPS buffer and transferred to
nylon membranes. A 1,200-bp fragment of the rat UCP cDNA
clone [kindly provided by Dr. D. Ricquier (7)] was used as a
probe by labeling with deoxy-[a-32P]CTP by use of random
primers (.108 cpm/µg DNA). Filters were hybridized for 20 h
at 50°C [40% formamide, 53 sodium saline citrate (SSC), 23
Denhardt’s solution, and 0.1% SDS] and washed 4 times in
23 SSC-0.2% SDS at room temperature for 15 min and then
twice in 0.13 SSC-0.2% SDS at 65°C for 20 min. Autoradio-
grams were obtained from the filters and quantified by laser
computer-assisted densitometry (Molecular Dymanics, Sun-
nyvale, CA). The membranes were routinely dyed using
methylene blue to visualize the ribosomal RNAs (rRNA), and
differences between lanes were used to correct the results
obtained from UCP mRNA. Usually rRNA is presented in the
figures. Some filters were also hybridized with the cDNA for
cyclophilin or vimentin as a loading control between lanes. All
experiments were repeated 2–3 times using duplicates. The
more complete and representative experiments are shown in
the figures, and the graphs show the means of 2–3 experi-
ments.
RESULTS
Adrenergic stimulation of UCP mRNA during differ-
entiation. The expression of UCP mRNA during the
differentiation of rat preadipocytes into adipocytes was
examined. The basal expression of UCP is undetectable
under standard culture conditions, namely 10% NCS
(Fig. 1, odd lanes). The presence of NE (10 µM) signifi-
cantly increased UCP mRNA (Fig. 1, even lanes, P ,
0.05) on any day after the cells reached confluence,
being maximal around confluence and decreasing there-
after (P , 0.05). NE does not increase UCP mRNA
during proliferation (day 3). The two bands correspond
to the two molecular sizes of the UCP mRNA, 1.6 and
1.9 kb. In Fig. 1 we also show, as control, the rRNA
pattern and the expression of vimentin, a constitutive
protein of the intermediate filaments in brown adipo-
cytes. Therefore, rat confluent cells are true brown
adipocytes, as they express UCP mRNA.
When 10% NCS is used, dose-response and time-
course experiments show that maximal effects are
obtained at 1 µM NE, a plateau is reached at higher
doses, and 2-h exposure to NE is enough to induce
significant increases (results not shown).
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Effect of T3 on the adrenergic response of UCP.
Because the responses to NE in the presence of NCS
were frequently very low, we analyzed the effect of T3 by
using several T3 concentrations, the effect of the differ-
entiation state of the cells, and the kinetics of induction
by NE and T3. The effect of T3 on the adrenergic
response of UCP mRNA expression was studied at days
6 and 8 (Fig. 2) by using 2 or 40 nM T3 for 20 h and 10
µM NE during the last 4 h (day 7 was also studied). In
the absence of NE, T3 per se does not increase UCP
mRNA levels. The adrenergic response when NE is
used in hypothyroid medium is barely detectable at day
6 and absent at day 8. But when T3 is added together
with NE, there is a marked potentiation of the adrener-
gic response [5–30 times, depending on the T3 concen-
tration used (P , 0.05), as well as on the time of
exposure to T3 (lower at 4 h, data not shown)]. This
effect of T3 is observed on any day after confluence.
The relationship between T3 and NE concentrations
was also examined to analyze the minimal dose of NE
or T3 required for the response of UCP mRNA. A
dose-response curve of NE in the presence of increasing
doses of T3 is represented in Fig. 3. Cells were exposed
to three different doses of T3 (0.1, 2, and 20 nM) for 20 h,
and for each T3 concentration, increasing doses of NE
were added for 4 h. When hypothyroid medium was
supplemented with a minimal dose of T3 (0.1 nM T3),
UCP mRNA expression was very low, even at the
highest NE dose (10 µM). When cells were preexposed
to 2 or 20 nM T3, the sensitivity of the response to NE
was multiplied severalfold, so that a detectable signal
was already observed when 0.1 µM NE and 2 nM T3
were used (lane 7) and became a strong signal when 0.1
µM NE and 20 nM T3 were used (lane 12) (P , 0.05). In
summary, the sensitivity of the adrenergic response is
increased ,100 times by preexposure to a tenfold
higher T3 dose, so that a similar UCP expression is
observed whether 10 µM NE 1 2 nM T3 or 0.1 µM NE 1
20 nM T3 is used. This experiment also shows that, at
very low T3 concentrations, the adrenergic response is
minimal and demands an increased NE concentration.
The smallest T3 concentration that increases UCP
mRNA expression is 0.2 nM T3 (Fig. 4, P , 0.05). This
Fig. 1. Adrenergic stimulation of uncoupling protein (UCP) mRNA
during differentiation. Rat brown precursor cells were grown in
standard conditions [10% newborn calf serum (NCS)] and, at differ-
ent days after seeding, incubated with 10 µM norepinephrine (NE)
during the last 4 h before recollection. Basal and stimulated UCP
mRNA, the ribosomal RNA (rRNA) stained with methylene blue,
vimentin mRNA, and densitometric analysis are depicted. Autorradio-
grams presented correspond to cells obtained from the same culture.
The experiment was repeated several times, checking 2 or 3 days/
experiment. Graph represents means 6 SE from several experi-
ments. All increases due to NE were significant (P , 0.05) vs. basal
levels. *P , 0.05 vs. days 6, 7, and 8.
Fig. 2. Effect of triiodothyronine (T3) on the adrenergic response of
UCP mRNA. Cultures of rat brown preadipocytes grown in standard
conditions were collected at days 6 and 8 after corresponding
treatments. Cells were maintained during the last 24 h in medium
containing 10% hypothyroid serum, supplemented or not with 2 or 40
nM T3, and 10 µM NE were added during the last 4 h before
recollection. UCP mRNA, rRNA stained with methylene blue, and
densitometric analysis are shown (means 6 SE of 2 experiments). All
increases due to NE were significant (P , 0.05) vs. basal levels,
except hypothyroid at day 8. *P , 0.05 vs. preceding T3 dose.
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demonstrates that the potentiation of the adrenergic
response by T3 is also obtained at very low T3 concentra-
tions. Higher T3 doses further increased UCP mRNA
(see Figs. 2, 3, and 5), a plateau being reached at 20 nM
T3 (with DMEM110% hypothyroid medium).
Kinetics of induction of UCP mRNA with NE and T3.
We also examined the minimal time required for both
NE and T3 to increase UCP mRNA levels. The kinetics
of induction by NE are shown in Fig. 5A in cells
preexposed for 24 h to 2 or 20 nM T3. NE requires ,2 h
to increase UCP mRNA, and the effect is quicker when
20 nM T3 is used, because at 2 h a strong signal is
already observed. The effects are prolonged throughout
24 h and amplified at the larger T3 dose.
The kinetics of induction for T3 were also studied
using two T3 doses (2 and 20 nM) during 4, 8, 16, or 28
h, when NE (10 µM) was added during the last 4 h (Fig.
5B). The effect of T3 on the adrenergic response is quick,
as it is obtained in ,4 h, and it is proportional to the
dose of T3 used (P , 0.05).
Effect of CHX and Act D on UCP gene expression. The
effect of T3 on the adrenergic stimulation is inhibited by
CHX, so it requires de novo protein synthesis. Figure
6A shows that CHX inhibits the induction observed by
use of NE, as well as NE1T3, at two different doses,
after either short (4 h) or long incubations (16–24 h).
The experiment was repeated several times and in
different conditions, and usually the inhibition was not
complete (50–70%).
We tested the effect of several doses of CHX (25, 15,
and 7.5 µM). These doses inhibited protein synthesis by
95.8, 94.1, and 91.8%, respectively, during 18 h, as
measured by the incorporation of 35S-methionine into
TCA-precipitable proteins. The CHX doses were added
0.5 h before T3 (18.5 h) or 0.5 h before NE (6.5 h). Figure
6B shows that all the CHX doses inhibited UCP expres-
sion, with a diminution of the effect at the lower CHX
dose used (7.5 µM) and at shorter times (6.5 h, just
before NE, lanes 7, 8, and 9). Act D (lane 3) completely
blocked the induction observed with the combined use
of NE1T3 (Fig. 6B).
Stabilization of UCP mRNA by T3. Figure 7 shows
the effect of T3 on the stabilization of the UCP mRNA
transcripts. The adrenergic stimulation of UCP mRNA
was tested by using two doses of T3, 10 nM and 0.5 nM
T3, in HS in the presence of NE. Act D was added after
12-h exposure to NE1T3, and cells were collected at
different times from 2 to 9 h. Results show that T3
stabilizes the UCP mRNA transcripts, increasing UCP
mRNA half-life from 5 to .24 h.
Other experiments were done in which different T3
doses were used (from 0.1 and 10 nM T3 in hypothyroid
medium), and the results obtained were similar, but
frequently the effect of the lower T3 doses (0.1–0.5 nM
T3) already stabilized UCP mRNA transcripts, prevent-
ing the discrimination between the low and high T3
doses. The experiment presented above rendered the
clearest results. Experiments in the complete absence
of T3, with HS, gave undetectable UCP mRNA levels.
Experiments in the presence of 10% NCS rendered a
UCP mRNA half-life of nearly 5 h.
Fig. 3. T3 potentiates effect of NE on UCP expression. Cultures of rat
brown preadipocytes, grown in standard conditions, were maintained
during the last 24 h in medium containing 10% hypothyroid serum,
supplemented with 0.1, 2, or 20 nM T3. Increasing doses of NE (0, 0.1,
1, or 10 µM) were added during the last 4 h before recollection at day
7. UCP mRNA, ribosomol RNAs (rRNA) stained with methylene blue,
and densitometric analysis are shown (means 6 SE of 2 experi-
ments). *P , 0.05 vs. basal levels.
Fig. 4. Dose-dependent induction of UCP mRNA using NE and T3.
Cultures of rat brown preadipocytes, grown in standard conditions,
were maintained during the last 24 h in medium containing 10%
hypothyroid serum, supplemented with increasing doses of T3 (0, 0.2,
0.5, 1, or 2 nM). NE (10 µM) was added during the last 4 h before
recollection at day 8. UCP mRNA, rRNA stained with methylene
blue, and densitometric analysis are shown (means 6 SE of 2
experiments). All increases due to T3 doses were significant (P , 0.05)
vs. basal levels.
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Effects of RA and T4. The effects of RA and T4 on the
adrenergic response were also examined and, in gen-
eral, were found to be less strong than when T3 was
used. Figure 8 shows a dose-response curve for T41NE.
The adrenergic stimulation is higher at either low or
high T4 concentrations, and lower at the intermediate
T4 doses. This experiment was repeated 3 times, with
doses ranging from 0.1 to 20 nM T4. The effect of T41NE
(at low doses) is much lower than that of T31NE (5
times lower, results not shown). In Fig. 9 we show the
effect of RA alone or with NE or NE and T3, compared
with T3. A clear effect of RA1NE is observed, although
it is lower than that of T31NE. RA does not synergize
with T3 or T31NE.
DISCUSSION
BAT thermogenesis is stimulated in vivo by the NE
released in the sympathetic nerve endings. The adren-
ergic stimuli induce the expression of UCP at the
transcriptional level, as demonstrated in vivo in rats (3,
6, 16, 35, 38) as well as in vitro, by use of cultures of
mouse brown adipocytes or cell lines (9, 21, 36). Most of
these increases are mediated through b-adrenergic
receptors, mainly b3-adrenergic receptors (9, 17–19, 21,
30, 36, 39), although the participation of an a1-
adrenergic component has also been suggested (36).
Most of the studies published on the regulation of UCP
mRNA expression have been performed using cultures
of brown adipocytes from mice or hamsters, species in
which the adrenergic stimulation is more easily demon-
strated (36), whereas studies using rat brown adipo-
cytes are scarce (9, 11). The reasons for this lack of
successful studies have not been clarified.
In the present paper, we show that UCP mRNA can
be stimulated adrenergically in primary cultures of rat
brown adipocytes obtained from precursor cells, demon-
strating that the cells obtained after proliferation and
differentiation in culture are true brown adipocytes,
because UCP expression is the specific marker of BAT.
The adrenergic stimulation of UCP, although weak, is
obtained at any day after the cells reach confluence,
indicating that, even when the accumulation of lipids
and lipogenic markers begins on later days (10, 29), the
cells are equipped for thermogenic functions and be-
have earlier as brown adipocytes. In the absence of NE,
the basal expression of UCP is absent when standard
culture conditions are used. Maximal adrenergic stimu-
lation of UCP is obtained around confluence, and no
increases are observed during active proliferation. In
this aspect, the results obtained in rat primary cultures
are similar to the ones described when primary cul-
tures of mouse preadipocytes are used (36). The stimu-
lation by NE is quick (2 h), suggesting, as described in
vivo, an activation at the transcriptional level (3, 35).
We observed that the stimulation is via b-adrenergic
receptors, in agreement with data obtained by other
authors (9, 19, 21, 36), and it is fully mimicked by
b3-adrenergic agonists (unpublished observations).
Nevertheless, the adrenergic stimulation of UCP
mRNA in primary cultures of rat adipocytes is gener-
ally weak or absent (even when different sources of
serum are used), and the optimal conditions for such
studies have not been described, except for one brief
study that compares UCP mRNA expression in mouse
and rat primary cultures (9). Thus studies on the
regulation of UCP mRNA in cultured rat brown adipo-
cytes are scarce (11). The low levels of UCP mRNA
observed in rat cultures after adrenergic stimulation
can be attributed to 1) growth factors or hormones
present in the serum used in the cultures that might
Fig. 5. Kinetics of induction of UCP mRNA by NE and T3. A:
time course for UCP induction by use of NE. Cultures of rat
brown preadipocytes, grown in standard conditions, were
maintained during the last 24 h in medium containing 10%
hypothyroid serum, supplemented with 2 or 20 nM T3. NE
(10 µM) was added and cells were collected 2, 4, 7, or 24 h
later. B: time course for UCP induction by use of T3. Cultures
of rat brown preadipocytes, grown in standard conditions,
were maintained during the last 24 h in medium containing
10% hypothyroid serum, supplemented with 2 or 20 nM T3
for different times (4, 8, 16, or 28 h). In each case, 10 µM NE
were added during the last 4 h before RNA extraction. UCP
mRNA, rRNA stained with methylene blue, and densitomet-
ric analysis are shown (means 6 SE of 2 experiments). All
increases were significant (P , 0.05) vs. basal levels and
different between T3 doses.
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inhibit the expression of UCP or 2) the low amount of T3
present in the culture medium, which we demonstrated
in this study to be essential for the NE effect. In fact,
although cellular T4 concentrations are normal, T4
concentrations measured in cultures using 10% NCS
were ,0.07 nM T3 in the medium and 0.7 nM T3 in the
cells, resulting in a cellular T3 concentration 5–6 times
lower than that found in BAT in vivo (3–4 nM, which
increases to 8 nM T3 after cold exposure; our unpub-
lished results). Thus we came to the conclusion that our
cells are really in hypothyroid conditions. This seems to
be due to the presence of active pathways for T3
degradation, namely, inner ring deiodinase activity
(DIII), activated in response to the serum used for
culture (13, 15). We have also demonstrated that, in the
same cultures of brown adipocytes (14), a minimal
amount of T3 is required for the adrenergic activation of
DII, the enzyme responsible for T3 production in BAT.
The main finding of the present work is that T3 is
absolutely necessary for the adrenergic stimulation of
UCP expression, reinforcing the results obtained in
rats in vivo and in floating adipocytes (2, 3, 46). In the
absence of thyroid hormones (hypothyroid medium),
the adrenergic stimulation of UCP is almost undetect-
able, and T3 potentiates the effect of a given NE dose.
We demonstrate that the effect of T3 takes place at any
day after confluence and is proportional to the dose and
time exposure to T3. T3 amplifies the adrenergic stimu-
lation of UCP by ,30-fold, depending on the T3 dose
used, and a 10-fold increase in T3 concentrations multi-
plies the NE effect by 100-fold. This gives an idea of the
magnitude and importance of the T3 effect. This T3
effect is already observed at very low T3 concentrations
(0.2 nM) in the lower physiological range. These facts
are easier to demonstrate in culture systems, where
those small changes can be handled, whereas in vivo,
potent mechanisms are present to maintain stable and
high T3 concentrations in BAT (increased T3 uptake and
high 5’ deiodination), so that the diminution of T3
concentrations and therefore of UCP expression would
be more difficult to show (26).
The effect of T3 is detected in ,4 h, suggesting an
effect on transcription, as already described (3, 35, 12),
although a maximal effect requires longer times with
the use of physiological T3 concentrations. This fact
suggests that the effect of T3 requires the synthesis of
an intermediate product and possibly de novo protein
synthesis. The experiments using CHX demonstrate
that this is the case. It is difficult to discern whether the
inhibitory effect of CHX is exerted on the action of T3 or
of NE, as separately each does not have an effect. The
inhibition seems to be exerted on the combined use of
NE1T3, possibly on a protein required for its combined
action. Nevertheless, the effect of CHX is more potent
when added before T3 (18 h) than when added after T3
and just before NE (6 h), suggesting that T3 per se is
able to induce the synthesis of a protein or transcrip-
tion factor required for the adrenergic stimulation of
UCP. These data are contrary to those reported in vivo,
where the T3 effect did not require de novo protein
synthesis (3).
Our data using Act D and the prompt responses
observed suggest that the effect is clearly at the tran-
scriptional level, confirming previous results (12, 35,
36). However, the full T3 effect is not only exerted at the
transcriptional level, because the effect on the stabiliza-
Fig. 6. Effect of cycloheximide (CHX) and actinomycin D (Act D) on
UCP mRNA. A: cultures of rat brown preadipocytes, grown in
standard conditions until day 6, were maintained during the last 24 h
in medium containing 10% NCS (lanes 1–3) or 10% hypothyroid
serum (HS). HS was supplemented with 2 or 20 nM T3 for 4, 16, or 24
h. NE (10 µM) was added during the last 4 or 16 h. CHX (15 µM) was
added to some tubes 30 min before NE (lanes 3, 5, 7, and 12). B:
cultures of rat brown preadipocytes, grown in standard conditions
until day 7, were maintained during the last 18 h in DMEM
containing 10% HS supplemented with 5 nM T3. NE (3 µM) was
added during the last 6 h before cell recollection. Act D (5 µg/ml) was
added 30 min before T3 addition (lane 3). Three doses of CHX (25, 15,
and 7.5 µM) were added 30 min before T3 addition (18.5 h, lanes 4, 5,
and 6) or 30 min before NE addition (6.5 h, lanes 7, 8, and 9).
Hybridization with a cyclophilin cDNA was used to correct for
differences between lanes (means 6 SE of 3 experiments). *P , 0.05
vs. NE1T3.
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tion of the mRNA transcripts seems even more impor-
tant, contributing to a marked elongation of UCP
mRNA half-life. Previous in vivo studies (35) described
a brisk increase in transcription during the first hour of
exposure of rats to cold, whereas the stabilization effect
takes place at longer times (8 h). In our cultured cells,
the stabilization effect is important even at low doses of
T3, making difficult a discrimination between low and
high T3 doses.
Important studies have been conducted to study the
effect of T3 on UCP at the promoter level, and an
enhancer region has been defined in the 22490/22280
bp of the rat UCP gene promoter (8, 34). Two TREs have
been defined at 22391/22376 (upTRE) and at 22348/
22334 (downTRE) (34), both of which seem needed for
the stimulation of UCP and the downTRE for the
potentiation of the cAMP effect by T3. Another group of
investigators (1) has identified three RAREs, in the
same region as the downTRE, at 22357/22330 (1),
whereas the former authors (33) define the RAREs
further upstream of the upTRE region (22490/22399).
It is very much a possibility that this enhancer region
might act promiscuously with both RA and T3 to
enhance UCP mRNA expression, and the results de-
pend on the specific proteins present in the transfection
cell system used or the origin of the cells used (32). In
contrast to the mouse UCP gene promoter in which
cAMP response elements (CREs) were described in an
enhancer element located in an enhancer region simi-
lar to that of the rat promoter (20), CREs were not
defined in the rat UCP promoter until recently (48), one
near the proximal promoter region and a second one
within the enhancer element described above (32). It
seems that the synergism between NE and T3 involves
interaction with a protein or coactivator, but this area
demands further investigation.
T3 has also been described to induce per se the
transcription of UCP mRNA without the concurrence of
NE (12) and to stabilize its mRNA in primary cultures
of fetal brown adipocytes. It is not clear whether this
fact is linked to the fetal state of the donor animals or to
the culture conditions used (serum-free medium), point-
ing to a possible inhibitory effect of serum on UCP
mRNA expression.
In our cultures, T4 also has an effect on the adrener-
gic stimulation of UCP mRNA expression. This effect is
much lower than that of T3 and follows a biphasic
pattern, suggesting that at low T4 doses (0.2 nM), the
effect is mediated through the generation of T3 from T4
Fig. 9. Effect of retinoic acid (RA) on UCP mRNA expression.
Cultures of rat brown preadipocytes, grown in standard conditions
until day 7, were maintained during the last 24 h in medium
containing 10% HS. T3 (5 nM), RA (100 nM), or both were added
during the last 18 h, and NE was added during the last 4 h. UCP
mRNA, rRNA stained with methylene blue, and densitometric analy-
sis are shown (means 6 SE of 4 experiments). *P , 0.05 vs. basal
levels.
Fig. 7. Stabilization by T3 of UCP mRNA transcripts. Cultures of brown preadipocytes, grown in standard
conditions until day 6, were maintained during the last 20 h in medium containing 10% HS supplemented with 10 or
0.5 nM T3, and NE (2 µM) was added during the last 12 h. Thereafter, Act D (5 µg/ml) was added and cells were
harvested 2, 4, 6, and 9 h later. UCP mRNA, cyclophilin cDNA, and densitometric analysis are shown (means 6 SE
of 2 experiments).
Fig. 8. Effect of thyroxine (T4) on adrenergic increases of UCP mRNA
expression. Cultures of rat brown preadipocytes, grown in standard
conditions until day 7, were maintained during the last 16 h in
serum-free medium supplemented with increasing doses of T4 (0, 0.2,
0.5, 1.5, 5, or 20 nM T4). NE (10 µM) was added during the last 4 h
before recollection. UCP mRNA, rRNA stained with methylene blue,
and densitometric analysis are shown (means 6 SE of 3 experi-
ments). *P , 0.05 vs. basal levels.
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through DII activity, when DII is not inhibited by T4
(45), whereas at higher T4 doses that inhibit DII, it
might be mediated through the occupancy of nuclear T3
receptors by T4. We find striking similarities between
the adrenergic stimulation of DII activity and UCP
mRNA expression with respect to the T3 requirements
(14). Both genes require the combined presence of T3
and NE to get adrenergic increases. In both, the
potentiating effect of T3 is large, increases with time,
and requires protein synthesis, and in both UCP and
DII, NE or T3 alone does not exert per se a significant
effect.
We have also found an effect of RA on the adrenergic
stimulation of UCP, somewhat lower than that of T3.
This is contrary to other reports using cultured murine
adipocytes (1, 31), where RA exerts a higher effect than
T3. Nevertheless, it has to be taken into account that, in
the last report, T3 was added to the medium to induce
differentiation, and the effect of RA should only be
considered as ‘‘pure’’ when depleted serum 1 RA were
used. The effects we observed are not synergic or
additive. This suggests that RA and T3 use the same
pathway to increase the adrenergic stimulation of UCP,
competing for the same sites or for the retinoid X
receptor present, because no synergism is found be-
tween T3 and RA. These results are also different from
the only report using floating rat brown adipocytes
stimulated with NE (33).
In summary, we have studied the conditions required
for the adrenergic stimulation of UCP in primary
cultures of rat brown adipocytes, especially with re-
spect to the need for T3. We conclude that there is an
absolute need of T3 for the adrenergic stimulation of
UCP mRNA, because in hypothyroid conditions, basal
and adrenergically induced UCP expression is absent.
The role of T3 in the stabilization of the mRNA tran-
scripts is also of major importance. However, the T3
effects are exerted at multiple levels: at the UCP
promoter, contributing to the stabilization of the tran-
scripts, and at other levels, such as the modulation of
the b-adrenergic receptor population (41, 42).
We thank Dr. D. Ricquier for the gift of the rat UCP cDNA.
This work was supported by Grants PB 92/0061 and PB 95/0097
from Direccio´n General de Investigacio´n Cientı´fica y Te´cnica and
Fondo de Investigaciones Sanitarias de la Seguridad Social Grant
94/0274 from Fondo de Investigaciones Sanitarias of Spain.
Address for reprint requests and other correspondence: M. J.
Obrego´n, Instituto Investigaciones Biome´dicas (C.S.I.C.), Arturo
Duperier 4, 28029 Madrid, Spain (E-mail: mjobregon@iib.uam.es).
Received 24 June 1999; accepted in final form 15 November 1999.
REFERENCES
1. Alvarez R, de Andre´s J, Yubero P, Vinas O, Mampel T,
Iglesias R, Giralt M, and Villarroya F. A novel regulatory
pathway of brown fat thermogenesis. Retinoic acid is a transcrip-
tional activator of the mitochondrial uncoupling protein gene. J
Biol Chem 270: 5666–5673, 1995.
2. Bianco AC, Kieffer JD, and Silva JE. Adenosine 3’,5’-
monophosphate and thyroid hormone control of uncoupling
protein messenger ribonucleic acid in freshly dispersed brown
adipocytes. Endocrinology 130: 2625–2633, 1992.
3. Bianco AC, Sheng X, and Silva JE. Triiodothyronine amplifies
norepinephrine stimulation of uncoupling protein gene transcrip-
tion by a mechanism not requiring protein synthesis. J Biol
Chem 263: 18168–18175, 1988.
4. Bianco AC and Silva JE. Intracellular conversion of thyroxine
to triiodothyronine is required for the optimal thermogenic
function of brown adipose tissue. J Clin Invest 79: 295–300,
1987.
5. Bianco AC and Silva JE. Nuclear 3,5,38-triiodothyronine (T3)
in brown adipose tissue: receptor occupancy and sources of T3 as
determined by in vitro techniques. Endocrinology 120: 55–62,
1987.
6. Bouillaud F, Ricquier D, Mory G, and Thibault J. Increased
level of mRNA for the uncoupling protein in brown adipose tissue
of rats during thermogenesis induced by cold exposure or norepi-
nephrine infusion. J Biol Chem 259: 11583–11586, 1984.
7. Bouillaud F, Weissenbach J, and Ricquier D. Complete
cDNA-derived amino acid sequence of rat brown fat uncoupling
protein. J Biol Chem 261: 1487–1490, 1986.
8. Cassard-DoulcierAM, Larose M, Matamala JC, Champigny
O, Bouillaud F, and Ricquier D. In vitro interactions between
nuclear proteins and uncoupling protein gene promoter reveal
several putative transactivating factors including Ets1, retinoid
X receptor, thyroid hormone receptor, and a CACCC box-binding
protein. J Biol Chem 269: 24335–24342, 1994.
9. Champigny O, Holloway BR, and Ricquier D. Regulation of
UCP gene expression in brown adipocytes differentiated in
primary culture. Effects of a new beta-adrenoceptor agonist. Mol
Cell Endocrinol 86: 73–82, 1992.
10. Garcı´a-Jime´nez C, Herna´ndez A, Obrego´n MJ, and San-
tisteban P. Malic enzyme gene expression in differentiating
brown adipocytes: regulation by insulin and T3. Endocrinology
132: 1537–1543, 1993.
11. Guerra C, Porras A, Roncero C, Benito M, and Fernandez
M. Triiodothyronine induces the expression of the uncoupling
protein in long term fetal rat brown adipocyte primary cultures:
role of nuclear thyroid hormone receptor expression. Endocrinol-
ogy 134: 1067–1074, 1994.
12. Guerra C, Roncero C, Porras A, Ferna´ndez M, and Benito
M. Triiodothyronine induces the transcription of the uncoupling
protein gene and stabilizes its mRNA in fetal rat brown adipocyte
primary cultures. J Biol Chem 271: 2076–2081, 1996.
13. Herna´ndez A and Obrego´n MJ. Presence of growth factors-
induced type III iodothyronine 5-deiodinase in cultured rat
brown adipocytes. Endocrinology 136: 4543–4550, 1995.
14. Herna´ndez A and Obrego´n MJ. T3 potentiates the adrenergic
stimulation of type II 58-deiodinase activity in cultured rat brown
adipocytes. Am J Physiol Endocrinol Metab 271: E15–E23, 1996.
15. Herna´ndez A, St Germain DL, and Obrego´n MJ. Transcrip-
tional activation of type III inner ring deiodinase by growth
factors in cultured rat brown adipocytes. Endocrinology 139:
634–639, 1998.
16. Jacobsson A, Nedergaard J, and Cannon B. a-Adrenergic
and b-adrenergic control of thermogenin messenger RNA expres-
sion in brown adipose tissue. Biosci Rep 6: 621–631, 1986.
17. Klaus S, Cassard-Doulcier AM, and Ricquier D. Develop-
ment of Phodopus sungorus brown preadipocytes in primary cell
culture: effect of an atypical beta-adrenergic agonist, insulin, and
triiodothyronine on differentiation, mitochondrial development,
and expression of the uncoupling protein UCP. J Cell Biol 115:
1783–1790, 1991.
18. Klaus S, Choy L, Champigny O, Cassard-Doulcier AM,
Ross S, Spiegelman B, and Ricquier D. Characterization of
the novel brown adipocyte cell line HIB-1B. Adrenergic pathways
involved in regulation of uncoupling protein gene expression. J
Cell Sci 107: 313–319, 1994.
19. Kozak UC, Held W, Kreutter D, and Kozak LP. Adrenergic
regulation of the mitochondrial uncoupling protein gene in
brown fat tumor cells. Mol Endocrinol 6: 763–772, 1992.
20. Kozak UC, Kopecky J, Teisinger J, Enerback S, Boyer B,
and Kozak LP. An upstream enhancer regulating brown fat-
specific expression of the mitochondrial uncoupling protein gene.
Mol Cell Biol 14: 59–67, 1994.
21. Kozak UC and Kozak LP. Norepinephrine-dependent selection
of brown adipocyte cell lines. Endocrinology 134: 906–913, 1994.
22. Morreale de Escobar G, Pastor P, Obrego´n MJ, and Esco-
bar del Rey F. Effects of maternal hypothyroidism on the weight
E776 T3 AMPLIFIES THE ADRENERGIC INCREASE OF UCP MRNA
and thyroid hormone content of rat embryonic tissues, before and
after onset of fetal thyroid function. Endocrinology 117: 1890–
1900, 1985.
23. Ne´chad M, Kuusela P, Carneheim C, Bjo¨rntorp P, Neder-
gaard J, and Cannon B. Development of brown fat cells in
monolayer culture. 1. Morphological and biochemical distinction
from white fat cells in culture. Exp Cell Res 149: 105–118, 1983.
24. Nedergaard J and Cannon B. [3H]GDP binding and thermo-
genin amount in brown adipose tissue mitochondria from cold-
exposed rats. Am J Physiol Cell Physiol 248: C365–C371, 1985.
25. Nicholls D, Cunningham SA, and Rial E. The bioenergetic
mechanisms of brown adipose tissue mitochondria. In: Brown
Adipose Tissue, edited by Trayhurn P and Nicholls DG. London:
Edward Arnold, 1986, p. 52–85.
26. Obrego´n MJ, Calvo R, Herna´ndez A, Escobar del Rey F,
and Morreale de Escobar G. Regulation of uncoupling protein
(UCP) mRNA and 58deiodinase (58D) activity by thyroid hor-
mones in fetal brown adipose tissue. Endocrinology 137: 4721–
4729, 1996.
27. Obrego´n MJ, Jacobsson A, Kirchgessner T, Schotz MC,
Cannon B, and Nedergaard J. Postnatal recruitment of brown
adipose tissue is induced by the cold stress experienced by the
pups. An analysis of mRNA levels for thermogenin and lipopro-
tein lipase. Biochem J 259: 341–346, 1989.
28. Obrego´n MJ, Pitamber R, Jacobsson A, Nedergaard J, and
Cannon B. Euthyroid status is essential for the perinatal
increase in thermogenin mRNA in brown adipose tissue of rat
pups. Biochem Biophys Res Commun 148: 9–14, 1987.
29. Pe´rez-Castillo A, Herna´ndez A, Pipao´n C, Santos A, and
Obrego´n MJ. Multiple regulation of S14 gene expression during
brown fat differentiation. Endocrinology 133: 545–552, 1993.
30. Puigserver P, Pico C, Stock MJ, and Palou A. Effect of
selective beta-adrenoceptor stimulation on UCP synthesis in
primary cultures of brown adipocytes. Mol Cell Endocrinol 117:
7–16, 1996.
31. Puigserver P, Vazquez F, Bonet ML, Pico C, and Palou A. In
vitro and in vivo induction of brown adipocyte uncoupling protein
(thermogenin) by retinoic acid. Biochem J 317: 827–833, 1996.
32. Rabelo R, Camirand A, and Silva JE. 38-58-Cyclic adenosine
monophosphate-response sequences of the uncoupling protein
gene are sequentially recruited during darglitazone-induced
brown adipocyte differentiation. Endocrinology 138: 5325–5332,
1997.
33. Rabelo R, Reyes C, Schifman A, and Silva JE. A complex
retinoic acid response element in the uncoupling protein gene
defines a novel role for retinoids in thermogenesis. Endocrinol-
ogy 137: 3488–3496, 1996.
34. Rabelo R, Schifman A, Rubio A, Sheng X, and Silva JE.
Delineation of thyroid hormone-responsive sequences within a
critical enhancer in the rat uncoupling protein gene. Endocrinol-
ogy 136: 1003–1013, 1995.
35. Rehnmark S, BiancoAC, Kieffer JD, and Silva JE. Transcrip-
tional and posttranscriptional mechanisms in uncoupling pro-
tein mRNA response to cold. Am J Physiol Endocrinol Metab 262:
E58–E67, 1992.
36. Rehnmark S, Ne´chad M, Herron D, Cannon B, and Neder-
gaard J. Alpha-adrenergic and beta-adrenergic induction of the
expression of the uncoupling protein thermogenin in brown
adipocytes differentiated in culture. J Biol Chem 265: 16464–
16471, 1990.
37. Ricquier D and Bouillaud F. The brown adipose tissue mito-
chondrial uncoupling protein. In: Brown Adipose Tissue, edited
by Trayhurn P and Nicholls DG. London: Edward Arnold, 1986,
p. 86–104.
38. Ricquier D, Bouillaud F, Toumelin P, Mory G, Bazin R,
Arch J, and Penicaud L. Expression of uncoupling protein
messenger RNA in thermogenic or weakly thermogenic brown
adipose tissue: evidence for a rapid b-adrenoreceptor-mediated
and transcriptionally regulated step during activation of thermo-
genesis. J Biol Chem 261: 13905–13910, 1986.
39. Rohlfs EM, Daniel KW, Premont RT, Kozak LP, and Collins
S. Regulation of the uncoupling protein gene (UCP) by beta 1,
beta 2, and beta 3-adrenergic receptor subtypes in immortalized
brown adipose cell lines. J Biol Chem 270: 10723–10732, 1995.
40. Ross SR, Choy L, Graves RA, Fox N, Solevjeva V, Klaus S,
Ricquier D, and Spiegelman BM. Hibernoma formation in
transgenic mice and isolation of a brown adipocyte cell line
expressing the uncoupling protein gene. Proc Natl Acad Sci USA
89: 7561–7565, 1992.
41. Rubio A, Raasmaja A, Maia AL, Kim KR, and Silva JE.
Effects of thyroid hormone on norepinephrine signaling in brown
adipose tissue. I: Beta 1- and beta 2-adrenergic receptors and
cyclic adenosine 38,58-monophosphate generation. Endocrinology
136: 3267–3276, 1995.
42. Rubio A, Raasmaja A, and Silva JE. Thyroid hormone and
norepinephrine signaling in brown adipose tissue. II: Differential
effects of thyroid hormone on beta 3-adrenergic receptors in
brown and white adipose tissue. Endocrinology 136: 3277–3284,
1995.
43. Samuels HH, Stanley F, and Casanova J. Depletion of
L-3,5,38-triiodothyronine and L-thyroxine in euthyroid calf serum
for use in cell culture studies of action of thyroid hormone.
Endocrinology 105: 80–85, 1979.
44. Silva JE and Larsen PR. Adrenergic activation of triiodothyro-
nine production in brown adipose tissue. Nature 305: 712–713,
1983.
45. Silva JE and Larsen PR. Interrelationships among thyroxine,
growth hormone, and the sympathetic nervous system in the
regulation of 58-iodothyronine deiodinase in rat brown adipose
tissue. J Clin Invest 77: 1214–1223, 1986.
46. Silva JE and Matthews PS. Full expression of uncoupling
protein gene requires the concurrence of norepinephrine and
triiodothyronine. Mol Endocrinol 2: 706–713, 1988.
47. Trayhurn P, Ashwell M, Jennings G, Richard D, and
Stirling DM. Effect of warm and cold exposure on GDP binding
and uncoupling protein in rat brown fat. Am J Physiol Endocri-
nol Metab 252: E237–E243, 1987.
48. Yubero P, Barbera MJ, Alvarez R, Vinas O, Mampel T,
Iglesias R, Villarroya F, and Giralt M. Dominant negative
regulation by c-Jun of transcription of the uncoupling protein-1
gene through a proximal cAMP-regulatory element: a mecha-
nism for repressing basal and norepinephrine-induced expres-
sion of the gene before brown adipocyte differentiation. Mol
Endocrinol 12: 1023–1037, 1998.
E777T3 AMPLIFIES THE ADRENERGIC INCREASE OF UCP MRNA
